期刊文献+

抗血管内皮生长因子Bevacizumab在眼部新生血管中的应用新进展 被引量:13

Recent advances in application of Anti-vascular endothelial growth factor Bevacizumab in ocular neovascularization
下载PDF
导出
摘要 眼部新生血管性病变是致盲的主要原因之一,大量的研究证据表明血管内皮生长因子(vascular endothelial growth factor,VEGF)是新生血管形成的关键调控因子。Bevaci-zumab是世界上首个批准上市的血管内皮因子抑制剂由于其强大的抗新生血管作用,在眼科新生血管性疾病治疗中有广泛的应用前景。本文对VEGF的特性、VEGF在眼部新生血管形成中的作用和Bevacizumab作用机制、应用范围进行综述。 Ocular neovascularization is the primary cause of blindness. There were extensive evidences that vascular endothelial growth factor (VEGF) was a major regulator of neovascularization. Bevacizumab, the first antivascular endothelial growth factor drug, had approved by the Food and Drug Administration. As anti-vascular endothelial growth factor drug, Bevacizumab may be beneficial to any ocular disease in which neovascularization and edema play a major role. The present paper focuses on VEGF and its role in ocular neovascularization and current anti-VEGF and Bevacizumab's mechanism, scope of application.
出处 《国际眼科杂志》 CAS 2008年第8期1644-1646,共3页 International Eye Science
关键词 新生血管 血管内皮生长因子 贝伐单抗 neovascularization vascular endothelial growth factor Bevacizumab
  • 相关文献

参考文献6

二级参考文献61

  • 1王启常,唐罗生.外源性VEGF诱导的大鼠视网膜血管病变[J].国际眼科杂志,2006,6(2):369-372. 被引量:8
  • 2周炼红,邢怡桥,陈春莲,汪道文.血管内皮生长因子反义核苷酸抑制大鼠角膜新生血管的实验研究[J].中华眼科杂志,2006,42(5):426-430. 被引量:9
  • 3廖瑞端 吴德正 等.低体重儿视网膜电图改变与发育有关的多因素分析[J].中华眼底病杂志,1995,11(3):151-151.
  • 4李贞,倪卫杰.视网膜新生血管生物药物治疗研究进展[J].国际眼科杂志,2007,7(4):1119-1123. 被引量:17
  • 5Robinson JR, Award IA, Zhou P, Barna BP, Estes ML. Expression of basement membrane and endothelial cell adhesion molecules in vascular malformation of the brain: preliminary observation and working hypothesis.Neurol Res,1995;17(1):49-58
  • 6Rothbart D, Award IA, Lee J, Kim J, Harbaugh R, Criscuolo GR. Expression of angiogenie factors and structural proteins in central nervous system vascular malformations. Neurosurgery, 1996;38(5):915-924, discussion 924-925
  • 7Vikkula M, Boon L, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB,Olsen BR. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE-2. Cell,1996;87:118
  • 8Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PM. Expression of structural proteins and angiogenic factors in cerebrovascular malformations.Neurosurgey,2000;46(5):1179-7791
  • 9Kirby ML, Waldo KL. Neural crest and cardiovascular patterning. Circ Res,1995;77:211-215
  • 10Fillinger MF, O'lonnor SE, Wagner RJ. The effect of endothelial cell coculture on smooth muscle cell proliferation. J Vasc Surg, 1993;17:1058-1067

共引文献50

同被引文献107

引证文献13

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部